Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy



Status:Archived
Conditions:Ocular
Therapuetic Areas:Ophthalmology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:October 2009

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Multicenter, Randomized, Double-Masked, Placebo-Controlled, Dose Escalation, Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACU-4429 in Subjects With Dry Age-Related Macular Degeneration (Geographic Atrophy)


The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and
pharmacodynamics of the investigational drug ACU-4429 in subjects with geographic atrophy.



We found this trial at
4
sites
Covance Clinical Research Unit, Inc.
Daytona Beach, Florida 32117
?
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Covance Clinical Research Unit
Austin, Texas 78752
?
mi
from
Austin, TX
Click here to add this to my saved trials
Covance Clinical Research Unit, Inc.
Dallas, Texas 75247
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Covance Clinical Research Unit, Inc.
Honolulu, Hawaii 96813
?
mi
from
Honolulu, HI
Click here to add this to my saved trials